In the corporate presentation it says the data package (due Q3) is going to be used to progress partnering opportunities - an email I sent off and got a reply to from the company states their BDM and outreach program has been "ongoing" but they obviously can't comment to the market further.
Makes me think they are currently in discussions, and I find it interesting that they have made particular reference to using this data package to "progress" partnering opportunities.
Not "commence" or "seek", but "progress".
Am doing my research prior to potentially buying in - wondering if any of the long termers can shed some light into this / who could be potential partners?
Ann: Oral nadolol data presented to American Thoracic Society, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.29M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $9.032K | 3.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4029980 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10133478 | 15 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| IVX (ASX) Chart |